Being set up on January of 2016, Avioq Bio-tech Co., Ltd. (hereinafter referred to as Avioq Bio-tech) is a wholly-owned subsidiary of Shandong Oriental Ocean Sci-Tech Co., Ltd.(hereinafter referred to as OOST) specializing in the development, production and marketing of IVD reagents.
Ever since being established, Avioq Bio-tech persists in the development philosophy of high starting point, high standards, high level and high quality. The company has built a GMP clean workshop of 4000 m2, including a 10,000-level production area, a 100,000-levelproduction area, a quality inspection area and the research lab.
Avioq mainly adopts such methodologies and technologies for the development and manufacturing of products as ELISA, homogeneous bio-chemical determination, colloidal gold and chemiluminescence etc. The company has received “Registration Certificate for Medical Device” for the following four kits: Pepsinogen I Assay Kit (CLIA), Pepsinogen I Assay Kit (ELISA), Pepsinogen II Assay Kit (CLIA) and Pepsinogen II Assay Kit (ELISA). Other main products being developed and registered include: Gastrin-17 Assay Kit (under registration and will obtain registration certificate soon), 7 EB (Epstein-Barr) virus assay kits (under clinical trials) and FMD Virus Assay Kit (registration inspection has been completed and will soon be tested clinically) and tumor-related projects (HE4, CA125, CA15-3, CA19-9, CA242, CA50, CA72-4)(registration inspection has been completed and will soon be registered). Avioq Bio-tech will apply for registration of other diagnostic reagents under the support of Avioq Inc., a wholly-owned subsidiary of OOST and the Medical Institute of Oriental Ocean (Beijing).